FAQ Library

FAQ Library published on June 14, 2017
Dr. Nooka discusses the crucial steps in identifying if your myeloma patient with cardiac history should receive carfilzomib and if so, when.
FAQ Library published on May 10, 2017
Join Dr. Usmani as he recommends the steps community oncologists should take to differentiate between, and provide ideal follow-up to, MGUS and smoldering MM patients.
FAQ Library published on April 12, 2017
Join Dr. Orlowski as he explains when to use daratumumab-lenalidomide-dexamethasone versus daratumumab-bortezomib-dexamethasone in clinical practice with multiple myeloma patients.
FAQ Library published on March 8, 2017
Join Dr. Usmani as he details the lab, biopsy-specific, and imaging-specific tests the community oncologist needs to consider when establishing a multiple myeloma diagnosis.
FAQ Library published on February 8, 2017
Join Dr. Orlowski as he defines aggressive symptomatic relapse and explains which drug regimens are recommended for rapidly progressing disease.
FAQ Library published on January 25, 2017
Join Dr. Orlowski as he recommends drug regimens for treating patients with asymptomatic biochemical relapse with slow versus rapid rise in M-protein levels.
FAQ Library published on November 8, 2016
Join Dr. Stadtmauer as he explains how to define and measure minimal residual disease (MRD) in patients with multiple myeloma, as well as the clinical implications of this technique to patient care.
FAQ Library published on November 3, 2016
Join Dr. Richter as he discusses the difference between smoldering myeloma and symptomatic multiple myeloma, and emerging criteria to classify and treat the former.
FAQ Library published on October 11, 2016
Join Dr. Giralt as he explains whether or not you should wait for the development of CRAB before initiating therapy for your multiple myeloma patients.
FAQ Library published on October 7, 2016
Join Dr. Landgren as he discusses the relative value of multicolor flow cytometry in an assessment for minimal residual disease (MRD) in multiple myeloma, compared to allele-specific PCR.
Page 2 of 12
Results 11 - 20 of 118